Charissa Tabora

Immunogenicity and safety of a varicella vaccine (Okavax) and a trivalent measles, mumps, and rubella vaccine (Trimovax) administered concomitantly in healthy Filipino children 12-24 months old.

S. Gatchalian, D. Leboulleux, Nancy Bermal, 2004, The American journal of tropical medicine and hygiene.

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14 weeks and 9 months of age

S. Gatchalian, A. Bandyopadhyay, P. N. Tingskov, 2019, Vaccine.